Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
October 15, 2021     Contact    
Featured This Week
 
Esports Entertainment Group Reports $8.8M Revenue in Q4, Up 63% Over Q3
 

 


Esports Entertainment Group (Nasdaq: GMBL) reported strong fourth quarter and fiscal year 2021 results, with revenue up 63% over Q3 to $8.8 million.


"The formidable foundation we built since our 2020 IPO drove strong performance in the fourth quarter and sets the stage for achieving significant growth in FY22. Based on a new record single-day performance of our iGaming division in late September, I am extremely confident in our ability to hit our guidance target," added Grant Johnson, CEO of Esports Entertainment Group. "The partnerships we have formed, from top professional sports teams to industry-leading esports and gaming companies, clearly demonstrate the strength of our expansive product and service portfolio, and I believe our future is very bright as we continue to execute on our rapid expansion strategy driven by the solidification of our market position and the ongoing growth of our unique assets."

 
 >
Latest News
 
Nano Dimension (NASDAQ: NNDM) to Deliver Fabrica 2.0 System to a Leading Western Homeland Security Agency Under a $1.5M Contract for Machine Utilization
 >
iSpecimen (NASDAQ: ISPC) Expands Global Biospecimen Supplier Network and Access to Human Biospecimens Needed to Help Accelerate Development of Liquid Biopsies
 >
Recruiter.com (NASDAQ: RCRT) CEO Featured on CNBC to Discuss Recruiter Index
 
 
BTCS (NASDAQ: BTCS) Announces Beta Release of Digital Analytics Platform
 
 
Milestone Scientific (NYSE American: MLSSs) Approved as Vendor to Supply CompuFlo Epidural/CathCheck Verification System Across Florida’s Memorial Healthcare System
 
 
Hut 8 (NASDAQ: HUT) Provides Production Update
 
 
SPI (NASDAQ: SPI) Issues $4.2M 10% Convertible Promissory Note with $20 per Share Conversion Price
 
 
DSS (NYSE American: DSS) Issued New CUSIP Number in Conjunction with Previously Announced Name Change
 
 
Kiromic BioPharma (NASDAQ: KRBP) Announces CFO Transition
 
 
Borqs Technologies Group’s (NASDAQ: BRQS) Announces Changes in Executive Positions
 
 
Cidara Therapeutics (NASDAQ: CDTX) Commences Concurrent Public Offering of Common Stock and Preferred Stock
 
 
Esports Entertainment Group (NASDAQ: GMBL) EEG Labs Partners with Alpha Esports to Design Computer Vision for Automated Scoring
 
 
Nutriband (NASDAQ: NTRB) Receives Notice of Allowance from US Patent Office for its AVERSA Technology
 
 
DeFi Technologies (OTC: DEFTF) Expands Executive Management Team as it Focuses on Growth in European and Global Markets along with New Product Launches
 
 
DeFi Technologies (OTC: DEFTF) Announces Appointment of Diana Biggs to HIVE Switzerland Board of Directors
 
 
CBD of Denver (OTC: CBDD) Reports Revenue of $2.6M in September on 26.5% Growth in Product Sold
 
 
 
Upcoming Zoom Webinar
 

Join Zoom Meeting: zoom.us/j/82291546417
One tap mobile :
US: +16465588656,,82291546417# or +13017158592,,82291546417#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 822 9154 6417
International numbers available:
zoom.us/u/kb6qct4XEt


 
 
 

Join Zoom Meeting: zoom.us/j/85870178926
One tap mobile :
US: +13126266799,,87571313126#,,,,*441144# or +16465588656,,87571313126#,,,,*441144#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 875 7131 3126
Passcode: 441144
International numbers available:
zoom.us/u/kb5Znq6Nw


 
 
 

Join Zoom Meeting: zoom.us/j/89140216416
One tap mobile :
US: +13017158592,,89140216416#,,,,*423133# or +13126266799,,89140216416#,,,,*423133#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 891 4021 6416
Passcode: 423133
International numbers available:
zoom.us/u/kqwdg9vnu


 
 
 

Join Zoom Meeting: zoom.us/j/85281332533
One tap mobile :
US: +16465588656,,85281332533# or +13017158592,,85281332533#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 852 8133 2533
International numbers available:
zoom.us/u/kbULT0Vx4


 
 
 

Join Zoom Meeting: zoom.us/j/81596779530
One tap mobile :
US: +13017158592,,81596779530# or +13126266799,,81596779530#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 815 9677 9530
International numbers available:
zoom.us/u/kbutRr3h17


 
 
 
 
 
 
 
Quote of the Week
 
"Get to know management, look for intelligence, a high level of integrity, strong communication skills and make sure they understand their products and business well."
- Byron Roth CEO of ROTH Capital Partners
 
 
 
Lesson of the Week
 
Learn the basics of value investing in this week's lesson.
Read More
 
 
 

 

Latest Videos
 
 
This Week on RedChip TV: Three Innovative Small-Cap Stocks
 
This week’s episode of the RedChip Money Report features interviews with Cidara Therapeutics (NASDAQ: CTDX), Defi Technologies (OTC: DEFTF), and Aptorum Group (NASDAQ: APM). Visit RedChip.com to learn more.
 
Watch Now
 
 
 
 
Nynja: World’s First Real-Time Collaboration and Payment Platform
 
Nynja was designed to address the frustration of having to use multiple apps to communicate and share documents with teams, clients, and business partners. With Nynja, users can message, call, video conference and share files all in one place, from their mobile device or desktop all while offering unique, real-time translation and transcription features that make it faster and easier to do business and send payments around the globe without regard to borders.
 
Watch Now
 
 
 
 
DeFi Technologies: Transforming Global Finance
 
DeFi Technologies (OTC: DEFTF) builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
 
Watch Now
 
 
 
 
Cidara Therapeutics: Major Partnerships & Phase 3 Studies Underway
 
Cidara (Nasdaq: CDTX) is developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases. The Company’s portfolio is comprised of new approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to drug-Fc conjugates (DFCs) targeting viral and oncology diseases from Cidara’s proprietary Cloudbreak® platform.
 
Watch Now
 
 
 
 
Aptorum Group: Robust Development Pipeline Targeting Multiple Indications
 
Aptorum Group (Nasdaq: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum's current drug pipeline includes indications in orphan diseases, infectious diseases, and metabolic diseases. In 2021, the company plans to bring two candidates to clinical trials.
 
Watch Now
 
 
 
 
Genetic Technologies: Commercializing Game-Changing Disease Risk Tests
 
Genetic Technologies (Nasdaq: GENE) is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health.
 
Watch Now
 
 
 
 
Nano Dimension: Transforming Electronics Manufacturing
 
Nano Dimension (Nasdaq: NNDM) is transforming the electronics and similar additive manufacturing sectors into an environmentally friendly & economically efficient additive manufacturing Industry 4.0 solution, while enabling a one-production-step-conversion of digital designs into functioning devices - on demand, anytime, anywhere.
 
Watch Now
 
 
 
 
Draganfly: Professional Drone Service Provider Positioned for Continued Rapid Growth
 
Draganfly (Nasdaq: DPRO) has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live.
 
Watch Now
 
 
 
 
Bragg Gaming: Well Positioned for Profitable Future Growth
 
Bragg Gaming Group (NASDAQ: BRAG) is a growing global gaming technology and content group and owner of leading B2B companies in the iGaming industry. Since its inception in 2018, Bragg has grown to include operations across Europe, North America and Latin America and is expanding into an international force within the global online gaming market.
 
Watch Now
 
 
 
 
Elys: World-Class B2B-Focused Betting Platform
 
Elys Game Technology (Nasdaq: ELYS) is a fully integrated, turnkey end to end international gaming technology company providing an innovative, world class Betting and i-Casino platform for land based and digital gaming operators. With over 20 years of experience in regulated sports betting and i-gaming operating, the company utilizes two distribution channels: retail land-based or on-site physical venues, and online through PC, tablet and mobile distribution, either directly to licensed operators or through value-added re- sellers or systems integrators in the leisure betting industry.
 
Watch Now
 
 
 
 
Tiziana Life Sciences (NASDAQ: TLSA) Provides Pipeline Updates in Exclusive Investor Webinar
 
Tiziana Life Sciences is a dual listed (NASDAQ: TLSA, UK LSE: TILS) biotechnology company that focuses on the discovery and development of novel molecules to treat human diseases in oncology, inflammation and infectious diseases. In addition to Milciclib, the Company will be shortly initiating Phase 2 studies with orally administered Foralumab for Crohn's Disease and nasally administered Foralumab for progressive multiple sclerosis.
 
Watch Now
 
 
 
 
Annovis Bio: Positive Phase 2 Data Sets Stage for Phase 3 Trials
 
Annovis Bio (NYSE American: ANVS) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Alzheimer’s in Down Syndrome (AD-DS). Annovis is believed to be the only company developing a drug for AD, PD and AD-DS that inhibits more than one neurotoxic protein and improves the information highway of the nerve cell, known as axonal transport.
 
Watch Now
 
 
 
 
Interview with Magellan Gold: Center Star Gold Mine Project and a Hedge Against Rising Inflation
 
Magellan Gold Corp. is focused on the exploration and development of precious metals in North America. Magellan’s near-term production strategy and the potential expansion of its resource base and project portfolio are expected to drive strong shareholder value improvement moving forward.
 
Watch Now
 
 
 
 
CEO interview with EVmo: Leading Rental Car Provider for gig economy drivers
 
EVmo (OTC: YAYO) bridges the gap between rideshare drivers in need of a suitable vehicle and rideshare companies that depend on attracting and keeping drivers. EVmo uniquely supports drivers in both the higher and lower economic categories with innovative policies and programs.
 
Watch Now
 
 
 
 
Medalist Diversified REIT: Restarted Dividend Payments in Q2 2021
 
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns.
 
Watch Now
 
 
 
 
Virios Therapeutics: Interview with CEO
 
Virios Therapeutics (Nasdaq: VIRI) is a clinical-stage biotechnology company focused on advancing novel, dual mechanism antiviral therapies to treat conditions associated with virally triggered or maintained immune responses, such as Fibromyalgia (“FM”).
 
Watch Now
 
 
 
 
CEO interview with Esports Entertainment: Projecting $100M+ Revenue Over Next 12 Months
 
Esports Entertainment Group is a full stack esports and online gambling company fueled by the growth of video-gaming and the ascendance of esports with new generations. Its mission is to help connect the world at large with the future of sports entertainment in unique and enriching ways that bring fans and gamers together.
 
Watch Now
 
 
 
 
Aridis Pharmaceuticals: Late-Stage Development of First-in-Class Anti-Infectives
 
Aridis Pharmaceuticals (Nasdaq: ARDS) is a late-stage clinical development company, leading the creation of transformative, first-in-class anti-infectives for life-threatening viral and bacterial respiratory infections. The company’s lead drug candidate for acute pneumonia met the primary endpoint for its phase 2 clinical trial and the Company is now enrolling in a global phase 3 study.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
Going back to 1936, the S&P has averaged a 6.7% return during the 1st year of a presidential term, 8.7% during the 2nd, 18.5% during the third and 9.8% during the 4th year.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2021 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.